Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

2021; Massachusetts Medical Society; Volume: 384; Issue: 6 Linguagem: Inglês

10.1056/nejmoa2023345

ISSN

1533-4406

Autores

Kimberly Page, Michael T. Melia, Rebecca T. Veenhuis, Matthew E. Winter, Kimberly E. Rousseau, Guido Massaccesi, William O. Osburn, Michael Forman, E. Donnall Thomas, Karla Thornton, Katherine Wagner, Ventzislav Vassilev, Lan Lin, Paula J. Lum, Linda C. Giudice, Ellen Stein, Alice Asher, Soju Chang, Richard L. Gorman, Marc G. Ghany, T. Jake Liang, Michael R. Wierzbicki, Elisa Scarselli, Alfredo Nicosia, Antonella Folgori, Stefania Capone, Andrea L. Cox,

Tópico(s)

Liver Disease Diagnosis and Treatment

Resumo

A safe and effective vaccine to prevent chronic hepatitis C virus (HCV) infection is a critical component of efforts to eliminate the disease.

Referência(s)